Novo Nordisk is slammed by U.K. trade group for not disclosing payments to health and patient groups A report found ‘the circumstances of this case … demonstrated poor governance’

https://www.statnews.com/pharmalot/2025/01/24/novo-nordisk-transparency-disclosure-obesity-wegovy-diabetes/